Rosemary Deshazo, M.D.
Internal Medicine Physician in Salt Lake City, Utah. This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 172,858 in Internal Medicine Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Rosemary Deshazo, M.D. reported a CMS MIPS final score of 94.8/100 - above the 83.1 national average - and filed 265 Medicare Part D claims in 2023.
- 94.8/100
- MIPS score · +12 vs avg
- 265
- Part D claims, 2023
- 78%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Rosemary Deshazo, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
95 Top 25% higher than 75% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Rosemary Deshazo, M.D. sits
This provider among internal medicine physician peers
Across the 36,260 internal medicine physician providers who report both Medicare Part D prescribing and a MIPS quality score, Rosemary Deshazo, M.D. writes more Part D claims than 30% of them and scores higher on MIPS quality than 78% - placing this provider in the lower-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one internal medicine physician peer from a representative sample of 60; the gold marker is Rosemary Deshazo, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Rosemary Deshazo, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Rosemary Deshazo, M.D.?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Utah
How Internal Medicine Physician compares to other specialties among Utah providers
Largest specialties in Utah (% of in-state providers)
Internal Medicine Physician ranks #18 among Utah's specialties (1.3% of in-state providers)
Each bar is a specialty's share of the Utah provider total, by primary NUCC taxonomy. The highlighted bar is Internal Medicine Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Rosemary Deshazo, M.D.'s 2023 MIPS final score plotted against the Internal Medicine Physician national average
- MIPS Final Score
- 94.8/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Internal Medicine Physician) - 94.8/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Internal Medicine Physician US NPIs
94.8/100 MIPS final score - 11.7 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Internal Medicine Physician. Quality dim: 90.6.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Rosemary Deshazo, M.D. appears in the CMS NPPES registry as a Internal Medicine Physician provider holding M.D. credentials at 50 N 1900 E, Salt Lake City, UT, 84132, with a listed phone of (801) 581-7606. NPI 1740346071 was issued on 12/29/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what Deshazo most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 265 prescription claims written by this provider, covering 109 Medicare beneficiaries and totaling roughly $239K in drug spend, split 22% brand-name and 78% generic by claim count. These figures capture only Medicare Part D, commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 94.8/100 for the 2023 performance year (Quality 90.6), compared with the national average of 83.1.
Internal Medicine Physician is a high-volume specialty nationwide, with 172,858 enrolled providers across 56 states and an average of 2,716 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1740346071 |
|---|---|
| Specialty | Internal Medicine Physician |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 12/29/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Rosemary Deshazo, M.D.'s current license status, disciplinary history, and board certifications with the Utah Division of Professional Licensing in Utah before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where Rosemary Deshazo, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Brand vs generic prescribing mix · Typical
22% brand-name claims vs 78% generic, on 265 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 348
- Total Day Supply
- 9,333
- Brand vs Generic
- 22% brand / 78% generic
- Brand Drug Cost
- $230K
- Generic Drug Cost
- $9K
Patient Demographics
- Average Patient Age
- 72.9 years
- Avg HCC Risk Score
- 1.16
- Gender Split
- 61% female / 39% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Rosemary Deshazo, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Triamcinolone Acet…
Triamcinolone Acetonide
44 claims
- Adbry
Adbry
23 claims
- Clobetasol Propion…
Clobetasol Propionate
23 claims
- Valacyclovir 15
Valacyclovir
15 claims
- Ketoconazole 14
Ketoconazole
14 claims
- Mycophenolate Mofe… 13
Mycophenolate Mofetil
13 claims
- Dupixent Syringe 11
Dupixent Syringe
11 claims
- Fluorouracil 11
Fluorouracil
11 claims
| Drug | Claims |
|---|---|
| Triamcinolone Acetonide | 44 |
| Adbry Tralokinumab-Ldrm | 23 |
| Clobetasol Propionate | 23 |
| Valacyclovir Valacyclovir Hcl | 15 |
| Ketoconazole | 14 |
| Mycophenolate Mofetil | 13 |
| Dupixent Syringe Dupilumab | 11 |
| Fluorouracil | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Internal Medicine Physician Overview
How Rosemary Deshazo, M.D. fits within the Internal Medicine Physician landscape nationally.
Rosemary Deshazo, M.D.'s 265 claims are below the specialty average of 2,716.
Nearby Internal Medicine Physician Providers in Utah
Other clinicians with the same primary specialty enrolled in Utah, drawn from the same CMS NPPES roster as Deshazo.
Compare Internal Medicine Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Utah medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Internal Medicine Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Utah
Frequently Asked Questions
What is Rosemary Deshazo, M.D.'s specialty? ▼
How much does Rosemary Deshazo, M.D. prescribe under Medicare Part D? ▼
What is Rosemary Deshazo, M.D.'s Medicare quality score? ▼
Where is Rosemary Deshazo, M.D. located? ▼
What is Rosemary Deshazo, M.D.'s NPI number? ▼
Does Rosemary Deshazo, M.D. prescribe more brand-name or generic drugs? ▼
How many Internal Medicine Physician providers are there in the US? ▼
What drugs does Rosemary Deshazo, M.D. prescribe most often? ▼
Does Rosemary Deshazo, M.D. accept Medicare? ▼
How can I verify Rosemary Deshazo, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology